Their results indicate that higher SUVmax is correlated with KRAS-positive status in colorectal cancer and pancreatic ductal adenocarcinoma [18,19,20,21,22], but in similar studies for NSCLC, this trend was not found in most of the previous studies [23,24,25], except in two [7,8]. Here, KRAS is linked to colorectal cancer.